En-tête de navigationNavigation principaleSuiviFiche


Unité de recherche
INNOSUISSE
Numéro de projet
13605.1;9 PFFLR-LS
Titre du projet
Creation of a new bioactive hyaluronic acid-based viscosupplement for intra-articular injection for arthritis
Titre du projet anglais
Creation of a new bioactive hyaluronic acid-based viscosupplement for intra-articular injection for arthritis.

Textes relatifs à ce projet

 AllemandFrançaisItalienAnglais
Description succincte
-
Anzeigen
-
Anzeigen
Résumé des résultats (Abstract)
-
Anzeigen
-
Anzeigen

Textes saisis


CatégorieTexte
Description succincte
(Anglais)
Creation of a new bioactive hyaluronic acid-based viscosupplement for intra-articular injection for arthritis.
Description succincte
(Français)
Creation of a new bioactive hyaluronic acid-based viscosupplement for intra-articular injection for arthritis
Résumé des résultats (Abstract)
(Anglais)
The goal of this project is to create a biocompatible and bio-stimulatory acid-based viscosupplement for intra-articular injection indicated to treat arthritis. Different hydrogels will be synthesized in relation to biological and mechanical studies for selection of viscosupplementation action and other innovative bio-stimulatory properties. This Medical Device will be prositioned as the only one which provides a proved action of biostimulation. In mid-2019, it would be projected to sell approximately 160'000 syringes of this new product. A letter, written by two leading Physicians in Orthopedics and Plastic Surgery, is supplied in this CTI application to support this innovative project.
Résumé des résultats (Abstract)
(Français)
The goal of this project is to create a biocompatible and bio-stimulatory acid-based viscosupplement for intra-articular injection indicated to treat arthritis. Different hydrogels will be synthesized in relation to biological and mechanical studies for selection of viscosupplementation action and other innovative bio-stimulatory properties. This Medical Device will be prositioned as the only one which provides a proved action of biostimulation. In mid-2019, it would be projected to sell approximately 160'000 syringes of this new product. A letter, written by two leading Physicians in Orthopedics and Plastic Surgery, is supplied in this CTI application to support this innovative project.